FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.22-SNAPSHOT | FHIR Version n/a User: [n/a]

1148744000: Lisocabtagene maraleucel (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Genetically modified T-cell (substance)\Lisocabtagene maraleucel
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Lisocabtagene maraleucel

\Biological substance\Immunologic substance\Genetically modified T-cell (substance)\Lisocabtagene maraleucel

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4551711011 Lisocabtagene maraleucel en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4551712016 Lisocabtagene maraleucel (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Lisocabtagene maraleucel	Is a	Genetically modified T-cell (substance)	true	Inferred relationship	Some
Lisocabtagene maraleucel	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing lisocabtagene maraleucel (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisocabtagene maraleucel	Inferred relationship	Some	1
Lisocabtagene maraleucel only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisocabtagene maraleucel	Inferred relationship	Some	1
Lisocabtagene maraleucel-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisocabtagene maraleucel	Inferred relationship	Some	1
Lisocabtagene maraleucel only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisocabtagene maraleucel	Inferred relationship	Some	1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
4551711011	Lisocabtagene maraleucel	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4551712016	Lisocabtagene maraleucel (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core